Formulation development of a stable influenza recombinant neuraminidase vaccine candidate
Current influenza vaccines could be augmented by including recombinant neuraminidase (rNA) protein antigen to broaden protective immunity and improve efficacy. Toward this goal, we investigated formulation conditions to optimize rNA physicochemical stability. When rNA in sodium phosphate saline buff...
Saved in:
| Main Authors: | Bing Li, Irina V. Ustyugova, Lisa Szymkowicz, Shaolong Zhu, Marin Ming, Karen Y. Y. Fung, Guadalupe Cortés, D. Andrew James, Michael Hrynyk, Nausheen Rahman, Roger H. Brookes, Salvador F. Ausar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2304393 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clade 2.3.4.4b H5N1 neuraminidase has a long stalk, which is in contrast to most highly pathogenic H5N1 viruses circulating between 2002 and 2020
by: Enikő Hermann, et al.
Published: (2025-04-01) -
Multivalent COBRA Hemagglutinin and Neuraminidase Influenza Vaccines Adjuvanted with TLR9 Agonist CpG 1018
by: Pedro L. Sanchez, et al.
Published: (2025-06-01) -
Neuraminidase activity and specificity of influenza A virus are influenced by haemagglutinin-receptor binding
by: Jimmy Chun Cheong Lai, et al.
Published: (2019-01-01) -
Discovery of Novel Natural Inhibitors of H5N1 Neuraminidase Using Integrated Molecular Modeling and ADMET Prediction
by: Afaf Zekri, et al.
Published: (2025-06-01) -
Neuraminidase Antibody Response to Homologous and Drifted Influenza A Viruses After Immunization with Seasonal Influenza Vaccines
by: Yulia Desheva, et al.
Published: (2024-11-01)